Nifty

:

22302.50

Sensex

:

73466.39

0.00 (0.00%)
-45.46 (-0.06%)

Login

Nifty
Sensex

:
:

22302.50
73466.39

0.00 (0.00%)
-45.46 (-0.06%)

Brooks Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

44/99

BSE: 533543 | NSE: BROOKS

Watchlist

NSE BSE

103.00

08-May-2024

Open
High
Low
Previous Close

100.10
103.00
100.00
102.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

24905
25.12
185.70
56.95

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

271.78
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

274.76
N/A
3.34

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-4.20
0.18
-6.47

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-7.02
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-11.17
2.55

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

2.88
3.34
3.34

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-0.28
-0.33
-0.33

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 21.75 12.00 81.25% 24.32 15.89 53.05% 15.70 14.94 5.09% 12.61 21.31 -40.83%
Expenses 20.65 13.47 53.30% 22.60 16.16 39.85% 15.68 18.98 -17.39% 12.73 20.97 -39.29%
EBITDA 1.10 -1.47 - 1.72 -0.27 - 0.02 -4.04 - -0.12 0.33 -
EBIDTM 5.04% -12.26% 7.06% -1.69% 0.15% -27.01% -0.95% 1.56%
Other Income 0.16 0.06 166.67% 0.09 0.07 28.57% 0.06 0.05 20.00% 0.02 0.37 -94.59%
Interest 0.21 0.24 -12.50% 0.19 0.19 0.00% 0.17 0.16 6.25% 0.18 0.23 -21.74%
Depreciation 0.43 0.43 0.00% 0.44 0.43 2.33% 0.44 0.42 4.76% 0.44 0.42 4.76%
PBT 0.60 -2.08 - 1.18 -0.82 - -0.53 -4.57 - -0.72 0.05 -
Tax 0.03 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.58 -2.08 - 1.18 -0.82 - -0.53 -4.57 - -0.72 0.05 -
PATM 2.65% -17.34% 4.85% -5.15% -3.39% -30.58% -5.72% 0.23%
EPS 0.22 -0.79 - 0.45 -0.31 - -0.20 -1.74 - -0.28 0.02 -

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 21.75 15.30 42.16% 24.32 18.08 34.51% 15.70 17.12 -8.29% 12.61 28.46 -55.69%
Expenses 20.65 23.86 -13.45% 22.60 27.31 -17.25% 15.68 25.72 -39.04% 12.73 32.37 -60.67%
EBITDA 1.10 -8.55 - 1.72 -9.23 - 0.02 -8.60 - -0.12 -3.91 -
EBIDTM 5.04% -55.90% 7.06% -51.03% 0.16% -50.22% -0.95% -13.74%
Other Income 0.16 0.09 77.78% 0.09 0.14 -35.71% 0.06 0.03 100.00% 0.02 0.18 -88.89%
Interest 0.21 0.75 -72.00% 0.19 0.63 -69.84% 0.17 0.62 -72.58% 0.18 0.84 -78.57%
Depreciation 0.43 2.33 -81.55% 0.44 2.28 -80.70% 0.44 1.98 -77.78% 0.44 1.95 -77.44%
PBT 0.60 -11.18 - 1.18 -12.00 - -0.53 -11.17 - -0.72 -6.52 -
Tax 0.03 -1.70 - 0.00 -3.85 - 0.00 -1.77 - 0.00 -0.58 -
PAT 0.58 -9.48 - 1.18 -8.14 - -0.53 -9.40 - -0.72 -5.94 -
PATM 2.65% -61.98% 4.85% -45.03% -3.39% -54.88% -5.72% -20.86%
EPS -1.48 -2.01 - -0.62 -1.88 - -1.79 -2.77 - -1.72 -1.44 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 74.38 55.54 76.97 77.27 69.69 55.03 55.71 57.54 80.01 85.21 85.27 Net Sales Growth 15.97% -27.84% -0.39% 10.88% 26.64% -1.22% -3.18% -28.08% -6.10% -0.07% Cost Of Goods Sold 52.11 40.46 49.27 47.77 46.84 39.43 39.38 36.66 52.95 60.65 58.55 Gross Profit 22.27 15.08 27.69 29.50 22.85 15.59 16.34 20.88 27.07 24.57 26.72 GP Margin 29.94% 27.15% 35.98% 38.18% 32.79% 28.33% 29.33% 36.29% 33.83% 28.83% 31.34% Total Expenditure 71.66 61.35 75.09 76.33 73.61 63.39 64.64 52.50 68.93 78.46 76.75 Power & Fuel Cost - 1.58 1.64 2.70 2.90 2.56 3.62 1.54 2.05 2.62 2.61 % Of Sales - 2.84% 2.13% 3.49% 4.16% 4.65% 6.50% 2.68% 2.56% 3.07% 3.06% Employee Cost - 10.65 10.88 12.04 11.16 10.04 9.65 6.16 5.20 3.75 2.56 % Of Sales - 19.18% 14.14% 15.58% 16.01% 18.24% 17.32% 10.71% 6.50% 4.40% 3.00% Manufacturing Exp. - 2.54 5.38 4.85 3.95 3.59 3.88 1.69 2.12 2.27 2.00 % Of Sales - 4.57% 6.99% 6.28% 5.67% 6.52% 6.96% 2.94% 2.65% 2.66% 2.35% General & Admin Exp. - 2.94 4.48 4.18 4.73 3.99 4.46 3.24 3.03 2.48 1.99 % Of Sales - 5.29% 5.82% 5.41% 6.79% 7.25% 8.01% 5.63% 3.79% 2.91% 2.33% Selling & Distn. Exp. - 1.52 1.68 1.54 0.95 0.73 1.03 1.82 2.05 4.89 6.82 % Of Sales - 2.74% 2.18% 1.99% 1.36% 1.33% 1.85% 3.16% 2.56% 5.74% 8.00% Miscellaneous Exp. - 1.67 1.75 3.24 3.08 3.05 2.61 1.39 1.54 1.81 6.82 % Of Sales - 3.01% 2.27% 4.19% 4.42% 5.54% 4.68% 2.42% 1.92% 2.12% 2.59% EBITDA 2.72 -5.81 1.88 0.94 -3.92 -8.36 -8.93 5.04 11.08 6.75 8.52 EBITDA Margin 3.66% -10.46% 2.44% 1.22% -5.62% -15.19% -16.03% 8.76% 13.85% 7.92% 9.99% Other Income 0.33 0.11 0.95 0.96 0.41 2.88 0.24 0.12 1.56 2.36 0.01 Interest 0.75 0.77 0.67 3.25 3.35 2.96 2.40 1.01 0.79 0.44 0.12 Depreciation 1.75 1.72 1.49 7.09 6.65 6.50 6.45 1.67 1.16 1.10 0.83 PBT 0.53 -8.19 0.67 -8.44 -13.51 -14.95 -17.53 2.48 10.69 7.57 7.57 Tax 0.03 0.00 0.00 7.15 10.86 -0.14 -3.72 0.82 0.19 0.88 0.33 Tax Rate 5.66% 0.00% 0.00% -84.72% -80.38% 0.94% 21.22% 33.06% 1.76% 8.50% 4.36% PAT 0.51 -8.19 0.67 -15.59 -24.38 -14.81 -13.81 1.67 10.63 9.47 7.24 PAT before Minority Interest 0.51 -8.19 0.67 -15.59 -24.38 -14.81 -13.81 1.67 10.63 9.47 7.24 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.69% -14.75% 0.87% -20.18% -34.98% -26.91% -24.79% 2.90% 13.29% 11.11% 8.49% PAT Growth 106.87% - - - - - - -84.29% 12.25% 30.80% EPS 0.19 -3.13 0.26 -5.95 -9.31 -5.65 -5.27 0.64 4.06 3.61 2.76

Description TTM Mar 23 Mar 22 Mar 21
Net Sales 74.38 63.20 91.18 77.25 Net Sales Growth -5.80% -30.69% 18.03% Cost Of Goods Sold 52.11 50.60 62.79 47.57 Gross Profit 22.27 12.60 28.40 29.67 GP Margin 29.94% 19.94% 31.15% 38.41% Total Expenditure 71.66 89.62 105.44 76.73 Power & Fuel Cost - 3.23 3.99 2.70 % Of Sales - 5.11% 4.38% 3.50% Employee Cost - 16.00 16.85 12.04 % Of Sales - 25.32% 18.48% 15.59% Manufacturing Exp. - 7.85 9.53 5.44 % Of Sales - 12.42% 10.45% 7.04% General & Admin Exp. - 4.07 6.37 4.19 % Of Sales - 6.44% 6.99% 5.42% Selling & Distn. Exp. - 1.68 1.69 1.54 % Of Sales - 2.66% 1.85% 1.99% Miscellaneous Exp. - 6.19 4.22 3.23 % Of Sales - 9.79% 4.63% 4.18% EBITDA 2.72 -26.42 -14.26 0.52 EBITDA Margin 3.66% -41.80% -15.64% 0.67% Other Income 0.33 0.20 0.80 0.74 Interest 0.75 2.18 3.10 3.10 Depreciation 1.75 7.03 7.35 7.14 PBT 0.53 -35.42 -23.90 -8.99 Tax 0.03 -7.32 -4.59 10.38 Tax Rate 5.66% 20.88% 19.21% -115.46% PAT 0.51 -20.90 -11.29 -19.38 PAT before Minority Interest 0.51 -31.05 -19.31 -19.38 Minority Interest 0.00 10.15 8.02 0.00 PAT Margin 0.69% -33.07% -12.38% -25.09% PAT Growth 101.55% - - EPS 0.19 -7.98 -4.31 -7.40

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 56.78 65.00 64.21 98.42 105.15 114.47 128.28 122.05 111.42 112.29 Share Capital 24.70 24.70 24.70 24.70 16.19 16.19 16.19 16.19 16.19 16.19 Total Reserves 32.08 40.30 39.51 73.71 83.41 98.29 112.09 105.86 95.23 96.10 Non-Current Liabilities 2.62 2.99 3.10 13.65 4.43 6.97 5.24 6.14 1.99 2.20 Secured Loans 0.00 0.00 1.34 11.40 13.86 16.63 10.73 0.34 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.46 1.65 1.54 1.72 1.48 1.08 1.51 4.34 0.66 0.61 Current Liabilities 33.02 35.46 25.69 45.80 47.39 40.48 24.26 27.92 22.14 17.97 Trade Payables 23.37 25.75 13.39 26.07 27.14 26.65 18.36 15.72 19.04 16.02 Other Current Liabilities 2.67 4.07 4.86 6.56 5.34 4.95 3.60 5.61 1.80 1.74 Short Term Borrowings 5.66 4.91 6.82 12.61 14.47 8.54 2.18 5.28 0.51 0.14 Short Term Provisions 1.32 0.74 0.63 0.56 0.44 0.35 0.13 1.31 0.78 0.08 Total Liabilities 92.42 103.45 93.00 157.87 156.97 161.92 157.78 156.11 135.55 132.46 Net Block 15.01 15.14 14.96 113.02 117.25 124.01 125.31 16.34 15.68 20.15 Gross Block 22.66 21.07 19.64 132.51 131.80 132.11 126.99 23.02 21.34 24.67 Accumulated Depreciation 7.65 5.93 4.68 19.49 14.54 8.10 1.67 6.68 5.65 4.52 Non Current Assets 64.82 66.42 65.13 119.95 125.23 131.23 135.91 126.18 80.76 74.48 Capital Work in Progress 0.00 1.12 0.02 0.11 0.29 0.52 0.00 86.86 52.86 37.16 Non Current Investment 46.85 46.84 46.81 0.02 0.47 0.65 0.65 0.02 0.02 0.02 Long Term Loans & Adv. 2.79 3.10 3.04 6.68 7.04 5.93 9.95 22.96 12.20 17.15 Other Non Current Assets 0.17 0.22 0.31 0.11 0.18 0.12 0.00 0.00 0.00 0.00 Current Assets 27.61 37.04 25.34 37.92 31.74 30.70 21.87 29.94 54.78 54.70 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 11.30 16.59 12.38 13.77 10.05 11.41 7.70 6.69 7.53 6.03 Sundry Debtors 12.75 15.03 9.59 15.56 11.42 10.18 10.69 18.91 19.29 16.46 Cash & Bank 1.08 1.08 0.88 1.53 3.32 1.96 1.84 2.23 22.92 29.99 Other Current Assets 2.48 1.41 0.61 6.42 6.95 7.13 1.65 2.11 5.03 2.22 Short Term Loans & Adv. 2.08 2.93 1.88 0.64 0.54 0.45 0.88 1.89 0.30 0.74 Net Current Assets -5.42 1.57 -0.34 -7.88 -15.65 -9.79 -2.39 2.02 32.64 36.73 Total Assets 92.43 103.46 90.47 157.87 156.97 161.93 157.78 156.12 135.54 132.47

Description Mar 23 Mar 22 Mar 21
Shareholder's Funds 73.95 87.49 79.15 Share Capital 24.70 24.70 24.70 Total Reserves 49.25 62.79 54.45 Non-Current Liabilities 2.62 11.36 19.31 Secured Loans 0.00 9.29 14.44 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 1.46 2.17 1.54 Current Liabilities 33.02 48.88 63.61 Trade Payables 23.37 28.00 30.95 Other Current Liabilities 2.67 8.80 17.89 Short Term Borrowings 5.66 11.05 13.64 Short Term Provisions 1.32 1.03 1.13 Total Liabilities 109.59 194.56 162.07 Net Block 15.01 110.01 107.56 Gross Block 43.79 142.81 133.42 Accumulated Depreciation 28.78 32.79 25.86 Non Current Assets 81.99 133.37 112.19 Capital Work in Progress 0.00 15.11 0.83 Non Current Investment 64.03 0.06 0.02 Long Term Loans & Adv. 2.79 7.97 3.48 Other Non Current Assets 0.17 0.22 0.31 Current Assets 27.61 61.18 47.36 Current Investments 0.00 0.00 0.00 Inventories 11.30 27.52 23.60 Sundry Debtors 12.75 17.66 13.70 Cash & Bank 1.08 3.81 1.70 Other Current Assets 2.48 1.55 0.65 Short Term Loans & Adv. 2.08 10.64 7.70 Net Current Assets -5.42 12.30 -16.25 Total Assets 109.60 194.55 159.55

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 0.56 3.12 -0.90 -9.39 -5.04 -6.18 9.56 8.12 2.13 10.65 PBT -8.19 0.67 -8.44 -13.51 -14.95 -17.53 2.48 10.69 7.57 7.57 Adjustment 2.79 2.43 10.23 11.76 9.24 9.83 3.26 0.67 -0.66 0.88 Changes in Working Capital 6.15 0.29 1.51 -7.62 1.22 2.31 5.55 2.15 -3.98 3.94 Cash after chg. in Working capital 0.75 3.39 3.30 -9.38 -4.48 -5.40 11.29 13.51 2.92 12.39 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.19 -0.26 -4.20 -0.01 -0.56 -0.78 -1.73 -5.39 -1.66 -1.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.87 0.00 Cash From Investing Activity -0.40 1.12 -0.74 -2.33 1.12 -5.14 -16.80 -13.56 -1.12 -10.64 Net Fixed Assets -0.47 -2.53 112.96 -0.53 0.54 -5.64 -17.11 -35.68 -12.37 -1.95 Net Investments -0.01 -0.03 -46.79 0.45 0.18 0.00 -0.63 0.00 0.00 0.00 Others 0.08 3.68 -66.91 -2.25 0.40 0.50 0.94 22.12 11.25 -8.69 Cash from Financing Activity -0.22 -4.22 1.31 9.61 5.78 11.82 7.01 4.32 -0.07 0.29 Net Cash Inflow / Outflow -0.06 0.02 -0.33 -2.10 1.85 0.51 -0.23 -1.12 0.94 0.31 Opening Cash & Equivalents 0.08 0.06 0.40 2.50 0.65 0.14 0.37 1.49 0.55 0.24 Closing Cash & Equivalent 0.02 0.08 0.06 0.40 2.50 0.65 0.14 0.37 1.49 0.55

Description Mar 23 Mar 22 Mar 21
Cash From Operating Activity -14.49 -37.44 4.46 PBT -35.43 -23.90 -8.99 Adjustment 9.69 11.05 10.29 Changes in Working Capital 11.40 -24.33 7.37 Cash after chg. in Working capital -14.34 -37.18 8.66 Interest Paid 0.00 0.00 0.00 Tax Paid -0.15 -0.26 -4.20 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity 0.49 -24.91 -5.13 Net Fixed Assets -0.47 -2.53 Net Investments -0.01 -0.03 Others 0.97 -22.35 Cash from Financing Activity 11.41 64.07 1.16 Net Cash Inflow / Outflow -2.58 1.72 0.49 Opening Cash & Equivalents 2.61 0.88 0.40 Closing Cash & Equivalent 0.02 2.61 0.88

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 22.76 26.06 25.99 39.84 51.31 58.97 66.08 62.87 57.40 56.15 ROA -8.36% 0.68% -12.43% -15.48% -9.29% -8.64% 1.06% 7.29% 7.06% 5.48% ROE -13.45% 1.03% -19.17% -24.62% -13.83% -11.38% 1.33% 9.11% 8.59% 6.86% ROCE -11.22% 1.87% -5.24% -7.77% -8.60% -10.64% 2.59% 9.69% 9.76% 7.24% Fixed Asset Turnover 2.54 3.78 1.02 0.53 0.42 0.44 0.86 3.61 3.70 3.48 Receivable days 91.32 58.39 59.40 70.66 71.64 66.94 83.32 87.15 76.58 81.63 Inventory Days 91.65 68.68 61.77 62.40 71.18 61.28 40.49 32.44 29.05 23.57 Payable days 221.56 144.92 150.71 126.49 149.31 121.22 121.35 94.73 84.10 69.81 Cash Conversion Cycle -38.60 -17.85 -29.54 6.57 -6.50 7.00 2.46 24.87 21.53 35.39 Total Debt/Equity 0.10 0.08 0.13 0.27 0.31 0.24 0.11 0.05 0.00 0.00 Interest Cover -9.68 1.99 -1.60 -3.03 -4.05 -6.29 3.46 14.62 24.34 64.73

Description Mar 23 Mar 22 Mar 21
Book Value (Rs.) 29.65 35.07 32.04 ROA -20.42% -10.83% -11.95% ROE -38.47% -23.18% -24.48% ROCE -37.84% -18.72% -5.33% Fixed Asset Turnover 0.68 0.66 0.58 Receivable days 87.83 62.77 64.72 Inventory Days 112.11 102.32 111.53 Payable days 185.27 171.35 237.48 Cash Conversion Cycle 14.66 -6.26 -61.23 Total Debt/Equity 0.08 0.28 0.40 Interest Cover -16.58 -6.72 -1.90

Top Investors:

quant mutual fund-business cycle fund

brj resources private

Annual Reports:

News Update:

Brooks Laboratories - Quarterly Results
31st Jan 2024, 18:05 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback